Arterial stiffness

There are 332 papers on arterial stiffness in aging research: 33 trials and 202 observational studies in people, 26 in animals, 64 reviews. The newest story, Nov 12, 2026: “Artery stiffness in mice tracked mouse age, not T cell age”.

Disease

332 papers study it1,289 more mention it24 findings

116 new papers in 30 daysSee all 1,621 papers on arterial stiffness

“A 1.4-fold, 2.2-fold increased risk for the new occurrence of arterial stiffness were documented in MHO and metabolically unhealthy obese participants compared to metabolically healthy normal-weight controls in the fully adjusted model.”
Risk of arterial stiffness according to metabolically healthy obese phenotype: a combined cross-sectional and longitudinal study in kailuan cohortAging2021doi:10.18632/aging.203075
  • Human trial33
  • Humans202
  • Animals26
  • In silico2

Interventions

1

SRT1720

downin mice1

1 study
  1. SRT1720 prevents arterial stiffness in Klotho-haplodeficient (KL+/-) mice.

    “Treatment with SRT1720 (15 mg/kg/d, IP), a specific SIRT1 activator, abolished Klotho deficiency-induced arterial stiffness and hypertension in KL+/- mice.”

    Animalsin Klotho-haplodeficient (KL+/-) mice15 mg/kg/d, IP

    Activation of SIRT1 Attenuates Klotho Deficiency-Induced Arterial Stiffness and Hypertension by Enhancing AMP-Activated Protein Kinase Activity

    Hypertension (Dallas, Tex. : 1979)

More on SRT1720

Upstream

1

CTF1

upin mice1

1 study
  1. CTF1 increases arterial stiffness in mice (shown by knockout in old mice).

    “The wall stress-incremental elastic modulus curve of old CT-1-null mice was shifted rightward as compared with wild-type mice, indicating decreased arterial stiffness.”

    Animalsshown by knockout in old miceartery

    Absence of cardiotrophin 1 is associated with decreased age-dependent arterial stiffness and increased longevity in mice

    Hypertension (Dallas, Tex. : 1979)

More on CTF1

Associations

20

Lipid Accumulation Product

upin humans2OR 1.88

2 studies
  1. Lipid Accumulation Product is associated with arterial stiffness in humans.

    “higher levels of lipid accumulation product (LAP), triglyceride/glucose index (TyG), and visceral adiposity index (VAI), are associated with increased arterial stiffness.”

    Humansn = 884

    Association Between Plasma Homocysteine, Folate, Vitamin B12 Levels, and Metabolic Dysfunction Indices in Elderly with Arterial Stiffness

    Journal of clinical medicine

  2. Lipid Accumulation Product is linked with a higher risk of arterial stiffness in humans (Q4 vs Q1, multivariate model) (OR = 1.88, 95% CI: 1.37-2.58).

    “Q4 of LAP was only associated with an increased risk of AS (odds ratio (OR) = 1.88, 95% confidence interval (CI): 1.37-2.58, P for trend < 0.001)”

    HumansQ4 vs Q1, multivariate model

    Association Between Lipid Accumulation Product and Target Organ Damage in Elderly Population: The Northern Shanghai Study

    Clinical interventions in aging

More on Lipid Accumulation Product

Weight-adjusted-waist index

upin humans1OR 1.808

1 study
  1. Weight-adjusted-waist index predicts arterial stiffness in humans (AUC 0.677).

    “Among the eight anthropometric indices, the AUC of WWI was the highest (overall, 0.677; men, 0.628; women, 0.708).”

    Humansn = 1,425

    Correlation analysis between eight anthropometric indicators and arterial stiffness in relatively healthy Chinese adults

    Frontiers in nutrition

  2. Weight-adjusted-waist index is associated with arterial stiffness in humans (unadjusted) (OR 1.808 (1.542-2.120)).

    “the odds ratios (ORs) for WWI were the largest compared with the other seven indices, at 1.808 (1.542-2.120)”

    Humansunadjustedn = 1,425

    Correlation analysis between eight anthropometric indicators and arterial stiffness in relatively healthy Chinese adults

    Frontiers in nutrition

More on Weight-adjusted-waist index

Physical activity

downin humans1OR 0.78

1 study
  1. Physical activity is linked with a lower risk of arterial stiffness in humans (fully adjusted model) (OR 0.78, 95% CI 0.72-0.84, -22% risk).

    “each standard deviation increase in PA intensity was associated with a 22% reduction in AS risk (odds ratio [OR] = 0.78, 95% confidence interval [CI]: 0.72-0.84, p < 0.001)”

    Humansfully adjusted model

    Association of physical activity with arterial stiffness: the mediating role of the visceral fat metabolism score

    Archives of endocrinology and metabolism

More on Physical activity

Model 1

upin humans1

1 study
  1. Model 1 predicts arterial stiffness in humans (validation cohort) (AUC 0.916).

    “In the derivation cohort, the AUCs for Model 1 and Model 2 were 0.926 and 0.927, respectively; in the validation cohort, both models achieved an AUC of 0.916.”

    Humansvalidation cohortarteryn = 2,512

    Two temporally validated diagnostic models for arterial stiffness using routine clinical indicators: a practical tool for resource-limited settings

    Frontiers in endocrinology

Remnant cholesterol

upin humans1

1 study
  1. Remnant cholesterol is associated with arterial stiffness in humans (P < 0.001).

    “Both hypertension and elevated RC were independently associated with an increased odds of AS (P < 0.001).”

    Humansn = 6,886

    Interaction of hypertension and remnant cholesterol on arterial stiffness in Chinese middle-aged and elderly populations

    Lipids in health and disease

More on Remnant cholesterol

Hypertension

upin humans1

1 study
  1. Hypertension is linked with a higher risk of arterial stiffness in humans (P < 0.001).

    “Both hypertension and elevated RC were independently associated with an increased odds of AS (P < 0.001).”

    Humansn = 6,886

    Interaction of hypertension and remnant cholesterol on arterial stiffness in Chinese middle-aged and elderly populations

    Lipids in health and disease

More on Hypertension

Metabolic syndrome-related visceral fat index

upin humans1OR 1.38

1 study
  1. Metabolic syndrome-related visceral fat index is associated with arterial stiffness in humans (fully adjusted model, Q4 vs Q1) (OR= 1.38, 95% CI 1.06 ~ 1.79, P =0.016).

    “In the fully adjusted model, compared with Q1, the participants in Q4 (OR= 1.38, 95% CI 1.06 ~ 1.79, P =0.016) exhibited an increase in arterial stiffness.”

    Humansfully adjusted model, Q4 vs Q1

    Association Between Metabolic Scores for Visceral Fat and Arterial Stiffness

    Vascular health and risk management

More on Metabolic syndrome-related visceral fat index

Creatinine-to-body-weight ratio

upin humans1OR 1.36

1 study
  1. Creatinine-to-body-weight ratio is associated with arterial stiffness in humans (OR 1.36 (95% CI 1.21–1.64)).

    “the fully adjusted ORs in the highest tertile of the Cre/BW ratio being 1.36 (95% CI, 1.21-1.64) and 2.09 (95% CI, 1.52-2.87), respectively.”

    HumansCross-sectional analysis; highest tertile of creatinine-to-body weight ratio; fully adjusted model

    Association between creatinine-to-body weight ratio and arterial stiffness: a cross-sectional and longitudinal study in the Chinese population

    Frontiers in cardiovascular medicine

More on Creatinine-to-body-weight ratio

Subendocardial viability ratio

upin humans1

1 study
  1. Arterial stiffness is associated with subendocardial viability ratio in humans.

    “occurrence of arterial stiffness and left ventricular diastolic dysfunction increased the potential of worse SEVR, with odds ratio 1.46 (1.17-1.83); P<0.001”

    Humansn = 3,237

    Subendocardial Viability Ratio Is Associated With Target Organ Damage and Hints at a Potential Independent Predictor of Cardiovascular Mortality in Older Adults: A Prospective Cohort Study

    Journal of the American Heart Association

More on Subendocardial viability ratio

Cardiometabolic disease

upin reviews1

1 study
  1. Cardiometabolic disease raises the risk of arterial stiffness.

    “Cardio-metabolic diseases increase the risk and progression of arterial stiffness”

    Review

    Impact of cardiometabolic risk factors and its management on the reversion and progression of arterial stiffness

    NPJ cardiovascular health

More on Cardiometabolic disease

All 20

Trial sponsors

Funding

38 grants since 2017

National Heart, Lung, and Blood Institute$13.5MNational Institute on Aging$26MNational Institute of Diabetes and Digestive and Kidney Diseases$4.1M

Latest

Dec 2025: 32Jan 2026: 44Feb 2026: 54Mar 2026: 54Apr 2026: 24May 2026: 40Jun 2026: 31Jul 2026: 27Aug 2026: 50Sep 2026: 47Oct 2026: 81Nov 2026: 42526 papers in 12 months
bioRxiv

Loss of nuclear support proteins harms mouse hearts and arteries

Median survival was 14.6% lower in artery-disease-prone mice lacking the proteins in blood-vessel-lining cells than in comparison mice.Median survival was 14.6% lower in artery-disease-prone mice lacking the proteins in blood-vessel-lining cells than in comparison mice.

Preprint: mouse studyMechanisms
Circulation Research

Restoring an enzyme improved blood vessel function in aged mice

Restoring the enzyme NNMT in cells lining blood vessels improved vessel widening and reduced arterial stiffness in aged mice; lowering NNMT worsened both.Restoring the enzyme NNMT in cells lining blood vessels improved vessel widening and reduced arterial stiffness in aged mice; lowering NNMT worsened both.

Mouse studyInterventions
GeroScience

Artery stiffness in mice tracked mouse age, not T cell age

Five weeks after receiving T cells from young or old donors, older mice had stiffer arteries regardless of the cells’ age.Five weeks after receiving T cells from young or old donors, older mice had stiffer arteries regardless of the cells’ age.

GeroScience

Hard-to-control blood pressure linked to signs of artery aging

An observational study initially identified 821 patients and linked resistant hypertension to stiffer arteries and blood-cell markers associated with senescence.An observational study initially identified 821 patients and linked resistant hypertension to stiffer arteries and blood-cell markers associated with senescence.

Cohort studyMechanisms

See all 1,621 papers on arterial stiffness